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Abstract In most pre-clinical animal studies investigating
stem cell therapy in acute myocardial infarction (AMI), the
administered stem cells are isolated from healthy donors. In
clinical practice, however, patients who suffer from AMI will
receive autologous cells, for example using adipose-derived
stem cells (ASC). During AMI, inflammation is induced and
we hypothesized that this might affect characteristics of ASC.
To investigate this, ASC were isolated from rat adipose tissue
1 day (1D group, n=5) or 7 days (7D group, n=6) post-AMI,
and were compared with ASC from healthy control rats
(Control group, n=6) and sham-operated rats (Sham 1D group,
n=5). We found that significantly fewer ASC were present
1 day post-AMI in the stromal vascular fraction (SVF), deter-
mined by a colony-forming-unit assay (p<0.001 vs. Control
and 7D). These data were confirmed by flow cytometry, show-
ing fewer CD90-positive cells in SVF of the 1D group. When
cultured, no differences were found in proliferation rate and cell
size between the groups in the first three passages. Also, no
difference in the differentiation capacity of ASC was found. In
conclusion, it was shown that significantly fewer stem cells
were present in the SVF 1 day post-AMI; however, the stem
cells that were present showed no functional differences.
Keywords Adipose-derived stem cells . Acute myocardial
infarction . Stromal vascular fraction .Mesenchymal stem
cells . Rat acute myocardial infarctionmodel
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AMI Acute myocardial infarction
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Introduction
Cardiovascular disease is still one of the main causes of mor-
tality and morbidity in the western world, with acute myocar-
dial infarction (AMI) as themost common cardiovascular entity
(Shah et al. 2011; Roger et al. 2012; Kuraitis et al. 2011).
Although life-saving treatments, such as pharmacotherapeutics
and percutaneous coronary intervention, have drastically im-
proved survival rate after AMI, these therapies do not restore
damaged myocardial tissue (Roger et al. 2012; Kuraitis et al.
2011; Pfeffer and Braunwald 1990). Regeneration of the myo-
cardium using adult mesenchymal stem cells, however, is a
promising solution to restore myocardium function and prevent
myocardium failure. This effect may either be reached by dif-
ferentiation of stem cells towards cardiomyocytes (Naaijkens
et al. 2012) or via the secretion of beneficial growth factors and
cytokines, the so-called paracrine effect (Boyle et al. 2011; Li
et al. 2009). In addition, it is possible to treat patients with their
own stem cells, thereby preventing a specific immune response
to the administered stem cells (Boyle et al. 2011; Pittenger et al.
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2004). In the previous decade, adult mesenchymal stem cells
were commonly isolated from bone marrow (bone marrow
mesenchymal stem cells; BM-MSC) (Friedenstein et al. 1974;
Prins et al. 2009). Recently, adipose tissue has become an al-
ternative, more easily accessible source, providing more mes-
enchymal stem cells per gram of tissue with a less painful
isolation procedure compared to a bone-marrow puncture. By
enzymatic digestion of adipose tissue, the stromal vascular frac-
tion (SVF) can be obtained. This is a heterogeneous population
of cells and contains amongst others endothelial cells, leuko-
cytes, fibroblasts, macrophages and ASC (Zuk et al. 2001;
Bourin et al. 2013). After seeding the SVF in tissue culture
plates using specific stem cell proliferation medium, the adher-
ent cell fraction consists almost solely of ASC (Zuk et al. 2001;
Bourin et al. 2013). ASC have been studied extensively in pre-
clinical AMI models, where they improved heart function and
reduced infarct size (Yamada et al. 2006; Mazo et al. 2012; van
Dijk et al. 2011).
Although BM-MSC therapy has proven to be safe in clin-
ical applications, it is not yet as beneficial in AMI patients as
in pre-clinical studies (Schachinger et al. 2006; Wollert et al.
2004; Janssens et al. 2006). Recently, the first clinical trial
using autologous ASC as cellular therapy after AMI
(APOLLO trial) only showed minor beneficial effects on
myocardial function (Houtgraaf et al. 2012). In all pre-
clinical studies that investigated stem cell therapy after AMI,
however, the administered stem cells were isolated from
healthy donors. In clinical practice, however, patients that suf-
fered from AMI receive their own stem cells. Importantly,
during AMI, many inflammatory mediators are released into
the blood stream (Kempf et al. 2006). In a recent in vitro study,
it was demonstrated that one of these mediators, TNFα, can
stimulate BM-MSC to activate macrophages to release the
anti-inflammatory interleukin-10 (Nemeth et al. 2009).
Conversely, it has been shown that TNFα can negatively in-
fluence differentiation of BM-MSC (Relic et al. 2006). We
hypothesized that the systemic inflammation caused by AMI
might adversely affect ASC within the highly vascularized
adipose tissue.
Therefore, we investigated whether stem cells isolated
from the inguinal fat pad of rats that suffered a temporal liga-
tion of the left anterior descending coronary artery, were dif-
ferent from stem cells isolated from healthy control rats. For
this, we analyzed the percentage of ASC within the SVF, and
studied expansion rate and differentiation capacity.
Materials and methods
Induction of infarction in rats
Animals were treated according to national guidelines and
with permission of the Institutional Animal Care and local
Animal Ethical Committee of the VU University Medical
Center (Amsterdam, The Netherlands), which conforms with
the National Institutes of HealthGuide for the Care and Use of
Laboratory Animals (NIH Pub. No. 85–23, Revised 1996).
Ma le Wis t a r r a t s (Har l an Labora to r i e s , Hor s t ,
The Netherlands; 300–400 g) were housed under constant
temperature (21–22 °C), humidity (60–65 %) and light–dark
periodicity (L:D 12:12; lights on from 0700 to 1900 hours).
Experimental procedures, started after 2 weeks of acclimati-
zation, were performed by an experienced researcher and pre-
viously described in detail (Naaijkens et al. 2014). In short,
rats were anaesthetized using subcutaneous hypnorm/
dormicum (fetanyl and fluanisone 0.5 ml/kg, midazolam
5 mg/kg) injection and ventilated at 75 breaths/min, 10–
0.4 mbar (Zoovent ventilator, The Netherlands). In an addi-
tional series of experiments, animals were sham-operated
(Sham group) or not operated (healthy control). These rats
were anaesthesized using sufentanil (50 μg/kg) and
medetomidine (150 μl/kg) subcutaneously. Because these ex-
periments had to be performed under different aneasthesia, as
hypnorm/dormicum was no longer available, an additional
healthy control group was also included. Data from the
sham-operated rats can therefore only be compared with the
second Control group (named ‘non-operated control group’).
These data are described in the BResults^, but not shown in the
graphs. Heart rate was monitored using an Einthoven I ECG.
A left thoracotomy was performed between the fourth and
fifth rib. Subsequently, a 6.0 prolene suture (Ethicon,
Germany) was placed around the left anterior descending cor-
onary artery in 12 rats. Ischemia was maintained for 40 min,
followed by reperfusion and chest closure. One rat died during
induction of the AMI and was excluded from the study. Rats
were sacrificed 1 day (1D group, n=5) or 7 days (7D group,
n=6) post-AMI. Healthy control rats (Control group, n=6)
were not operated on. Additional sham-operated rats (Sham
group, n=5) were operated and the suture was placed, but not
tightened, and no infarction was induced. Sham-operated rats
were sacrificed 1 day post-operation.
Analysis of infarction area
Immediately after sacrificing the rats, the hearts were excised
and the part of the heart below the suture was cut into 3 equal
cross-sections (approximately 2 mm thick). These cross-
sections were then snap-frozen in liquid nitrogen. For analysis
of the infarcted area, 4-μm cryostat tissue sections were cut
from each of the heart cross-sections and transferred onto
superfrost tissue slides. The slides were fixed in 100 % ace-
tone for 10 min and washed five times with PBS. Next, the
slides were incubated in Bouin at 60 °C for 30 min, cooled for
15 min, and then washed in water for 10 min. The slides were
incubated in phosphotungstic acid haematoxylin (PTAH) at
60 °C for 30 min. After cooling, they were dehydrated,
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washed in xylene and covered. The slides were scanned (Zeiss
light microscope) and the surface areas of the total heart cross-
section and of the infarcted area were measured using ImageJ
software. For the three cross-sections, the infarcted areas were
determined as the percentage of the respective surface areas of
the total cross-section surface areas and then averaged to pro-
duce the final infarcted areas.
Isolation of the SVF from rat adipose tissue and culture
of ASC
Directly after sacrifice, adipose tissue from the inguinal fat
pad of male Wistar rats (Harlan) was resected, transferred to
sterile PBS and processed immediately, as previously
described by van Dijk et al. (2011). The isolation of the SVF
cells was performed by an experienced researcher, and rats of
the different groups were randomized over different isolation
days. In short, adipose tissue was minced and washed with
PBS. Then, the extracellular matrix was enzymatically
digested with 0.0125 % Liberase™ Research Grade medium
Thermolysin (Roche Diagnostics, Indianapolis, USA) under
continuous shaking at 37 °C for 25 min. The mixture was
filtered (100 μm; Codan, Germany) and centrifuged (5 min,
600g). The supernatant was discarded and the cell-containing
pellet was resuspended in PBS and centrifuged (5 min, 600g).
The total number of cells (stromal vascular fraction; SVF) was
counted, and either frozen in Recovery cell culture freezing
medium (Gibco, Invitrogen, CA, USA) and stored in liquid
nitrogen, or directly used in experiments.
Colony-forming-unit assay
To assess the percentage of colony-forming cells present in the
SVF, a colony-forming-unit assay was performed, which is an
assay to determine the percentage of ASC present in the SVF
(Bourin et al. 2013). For this, SVF cells were seeded at a
density of 10 and 100 cells/cm2 (in triplicate) and cultured in
normal proliferation medium containing DMEM medium,
supplemented with 10 % fetal bovine serum (FBS), 1 %
penicillin/streptomycin and 1 % L-glutamine (all from
Gibco). Cells were maintained at 37 °C, 95 % humidity and
5 % CO2. After 14 days, the cells were washed with PBS,
fixed with 4 % formalin for 10 min, and subsequently stained
in a 1% toluidine blue solution in borax buffer for 1min. After
washing with water, colonies of approximately 50 cells or
more were scored using a stereomicroscope (Zeiss, Germany).
ASC culture
For culturing of ASC, the SVF was seeded at 100,000 cells/
cm2 in 25 cm2 tissue culture plastic and cultured in normal
proliferation medium. Cells were counted after 4 days to de-
termine the number of cells, or grown to near confluency
(90 %) and used in further experiments. ASC were detached
with 0.5 mM EDTA/0.05 % trypsin (Gibco). Cell size was
determined using a Scepter handheld automatic cell counter
(Millipore, Billerica, MA, USA). Population doubling time
was determined by seeding 2500 cells/cm2 (passage 1) in du-
plicate. When cells reached 90 % confluence, they were har-
vested and counted with the Scepter handheld automatic cell
counter (Millipore). Population doubling time was calculated
by dividing the number of days before passaging by the num-
ber of cell doublings. This was repeated for passages 2 and 3.
Flow cytometry
Freshly isolated SVF and cultured ASC were phenotypically
characterized using fluorescence-activated cell sorting (FACS;
FACS Calibur, Becton Dickinson, USA). Cells were harvest-
ed and washed with FACS buffer (PBS containing 1 % BSA
and 0.05 % sodium azide). Thereafter, cells were incubated
with the appropriate antibodies in FACS buffer at RT for
30 min. The following primary antibodies were used: phyco-
erythrin (PE)-conjugated mouse-α-rat antibodies against
CD90 (1:20; Cedarlane Laboratories, Ontario, Canada),
CD45 (1:20; BD Biosciences, San José, CA, USA), CD271
(1:25; BD Biosciences) and CD31 (1:20; AbD Serotec,
Oxford, UK), PE-labeled mouse α-human antibody CD105
(1:25; Caltag, Invitrogen, USA), as well as unlabeled
mouse-α-rat antibodies against CD34 (1:20; Santa Cruz
Biotechnology) and CD73 (1:20; BD Biosciences). After in-
cubation, the cells were washed with FACS buffer. For CD34
and CD73, a fluorescein isothiocyanate (FITC)-conjugated
goat-α-mouse secondary antibody was used (1:30; BD
Biosciences). After a 30-min incubation period at RT, cells
were washed with FACS buffer, centrifuged and resuspended
in 100 μl FACS buffer. Isotype control PE- and FITC-
conjugated IgG1 antibodies (both BD Biosciences) were used
to determine nonspecific fluorescence. Data were analyzed
using CellQuest-Pro software and expressed as percentage
of positive cells.
Osteogenic differentiation
To assess the differentiation capacity of ASC towards osteo-
blasts, ASC (passage 1) were seeded in 12-well culture dishes
at 10,000 cells/cm2. The cells were then cultured in monolayer
in Osteogenesis Differentiation Medium (Gibco). Control
cells were cultured in normal culture medium. Both differen-
tiation and control media were changed twice a week.
Differentiation was stopped at 12 days by fixating the cells
with 4 % formaldehyde at RT for 10 min. Differentiation was
demonstrated by staining alkaline phosphatase (ALP). For
this, cells were incubated in 0.2 M TRIS-hydrochloride
(pH 10), 0.2 M calcium, 0.1 M magnesium chloride solution
for 10 min, whereafter a solution containing 0.2 M TRIS-
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hydrochloride (pH 10), 0.2 M calcium chloride, 0.1 M mag-
nesium chloride solution and nitroblue tetrazolium/5-bromo-
4-chloro-3-indolyl-phosphate (NBT/BCIP) was added (1:100,
Roche Diagnostics, Mannheim, Germany) for 15 min. This
stains ALP blue. Microscopic images were taken using a Zeiss
microscope.
Adipogenic differentiation
To assess the differentiation capacity of ASC towards adipo-
cytes, ASC (passage 1) were seeded in 12-well culture dishes
at 5000 cells/cm2. The cells were then cultured in monolayer
in Adipogenic Differentiation Medium (Gibco). Control cells
were cultured in normal culture medium. Both differentiation
and control media were changed twice a week. Differentiation
was stopped at day 7 by fixating the cells with 4 % formalde-
hyde for 10 min and with Baker’s calcium formalin for
60 min, both at RT. Subsequently, the cells were washed with
isopropanol 60 %, incubated with a filtered Oil Red-O solu-
tion (15 min at RT), and counterstained with hematoxylin
(5 min at RT). Lipid vesicles, which are a characteristic of
adipocytes, were stained in red. Microscopic images were
taken using a Zeiss microscope.
Cardiomyocyte differentiation
To assess the differentiation capacity of ASC towards
cardiomyocytes, ASC (passage 1) were seeded in a density
of 5000 cells/cm2 on laminin-coated (0.2 μg/cm2) tissue cul-
ture plastic. Cells were stimulated with 5-aza-2-deoxycytidine
(9 μM; Fluka, Sigma Aldrich, St. Louis, MO, USA) for 24 h
in DMEM supplemented with 15% FBS, 100 U/ml penicillin,
100 μg/ml streptomycin, 2 mM L-glutamine and 1 % ITS+
premix (BD Biosciences). Control cells were cultured in nor-
mal culture medium. Both cardiomyogenic and control media
were changed twice a week. Cells were harvested after
12 days. Cytospin slides were prepared by spinning ASC onto
glass microscope slides at 500 rpm for 5 min (Shandon
cytospin 3; Thermo Scientific, Waltham, MA, USA). Slides
were air-dried overnight, fixed with acetone for 10 min, and
incubated with a rabbit-α-rat connexin 43 antibody (1:1000;
Invitrogen) or with a rabbit-anti-rat cardiac Troponin I (cTnI)
an t ibody (1 :250 ; Abcam) in Ant ibody Di luen t
(ImmunoLogic, Duiven, The Netherlands) at RT for 60 min.
As secondary antibody, a biotin-labeled α-rabbit antibody
(1:100) was used for both stainings, followed by incubation
of streptavidin/HRP (1:200; both DakoCytomation, Glostrup,
Denmark), both at RT for 30 min. Slides were washed with
PBS after each step. Stainings were visualized using 5-min
incubation with aminoethylcarbazole (AEC; Zymed AEC
kit, Invitrogen). Finally, cells were counterstained with hema-
toxylin and covered. PBS control slides were incubated with
PBS instead of the primary antibody and showed no positive
staining. Microscopic images were taken using a Zeiss micro-
scope and all cytospin slides were scored for the percentage of
connexin 43 and cTnI-positive cells.
Statistical analysis
Statistical analysis was performed with GraphPad Prism 5.
Groups were tested for normal distribution with the one-
sample Kolmogorov–Smirnov test. A Student’s t test or
ANOVA with the Bonferroni post hoc test was used, since
all values were distributed normally. A p value smaller than
0.05 was considered to represent a statistically significant dif-
ference. Data are presented as mean±standard deviation.
Results
Induction of an acute myocardial infarction
Acute myocardial infarction was induced in rats, whereafter
adipose tissue was collected at day 1 (1D group, n=5) or at
day 7 (7D group, n=6) post-AMI, followed by isolation of SVF
cells (see Fig. 1a). As a control, SVF cells were isolated from
healthy rats without AMI (Control group, n=6). The success of
the operational AMI procedure was determined by histological
stainings for infarct size of heart slides with PTAH. For this,
heart slides were evaluated distal from the suture placed on the
left coronary artery descendent. A representative image of the
PTAH staining of an infarction is shown in Fig. 1b. Infarct size
of the 1D group was 7.2±2.8 % of the myocardium, while the
7D group had an infarct size of 11.7±5.7 % (Fig. 1c).
Composition of the SVF after AMI
The SVF was analyzed for cell size, the percentage of ASC,
and cell surface marker profile.
No significant differences were found in average size of
SVF cells directly after isolation between the different groups
(Fig. 2a). To determine the percentage of ASC in the SVF
fraction, a colony-forming-unit assay was performed (Bourin
et al. 2013). The percentage of colony-forming cells, analyzed
after 14 days of culture, was 11.4±1.8 % in the Control group
and 11.0±0.9 % in the 7D group. Interestingly, in the 1D
group, significantly fewer colonies were formed (6.1±1.6 %,
p<0.01 compared with both groups), as shown in Fig. 2b. In
addition, in the sham group, a similar number of colony-
forming cells was found 1 day post-operation, as compared
with the non-operated control rats. In line with this, culturing
the SVF cells for 4 days resulted in significantly fewer cells in
the 1D group (1.3±0.1 million cells) compared with the
Control group (2.0±0.1 million cells, p<0.05) and the 7D
group (1.8±0.1 million cells, p<0.05), as depicted in
Fig. 2c. Furthermore, the cell surface marker profile of the
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SVF cells showed significantly fewer CD90-positive cells in
the 1D group (29.1±6.3 %) compared with the Control group
(41.1±6.9 %, p<0.05) and with the 7D group (42.1±7.4 %,
p<0.05). In addition, significantly fewer CD105-positive cells
were present in the 1D group (48.7±6.3 %) compared with
Control (59.1±4.3 %, p<0.05) and 7D groups (61.0±5.9 %,
p<0.05). These results theoretically indicate that fewer ASC
were present in the SVF of the 1D group. The same trend
was observed for the percentage of positive cells in the 1D
group for stem cell-associated markers CD34 (Control group
14.4±5.1 %, 1D group 9.4±4.9 %, 7D group 15.6±7.8 %,
p>0.05), CD73 (Control group 33.3±8.3 %, 1D group 24.8
±10.1 %, 7D group 37.9±8.8 %, p>0.05) and CD271
(Control group 5.1±4.1 %, 1D group 2.8±0.8 %, 7D group
5.9±5.2 %, p>0.05) (Fig. 2d). No change was found for the
percentage of CD31-positive cells, an endothelial cell marker
(Control group 16.2±4.8 %, 1D group 15.2±10.3 %, 7D
group 16.4±10.9 %, p>0.05), or for the percentage of
CD45-positive cells, a marker for leukocytes (Control group
53.5±5.2 %, 1D group 46.9±10.4 %, 7D group 46.4±14.8 %,
p>0.05). These results show changes in cellular composition
of the SVF 1 day after AMI, with less ASC in the SVF in the
1D group. Sham-operated rats showed similar cell surface
markers as non-operated control rats (not shown).
Effect of AMI on functional characteristics of ASC
After culturing the heterogenous SVF in stem cell prolifera-
tion medium, a more homogenous ASC population was ob-
tained. Characteristics of these cultured ASC, such as mor-
phology, proliferation, cell size and surface marker profile,
were determined. ASC from both AMI groups showed similar
morphology and this was no different from the Control group
(representative image shown in Fig. 3a). ASC were cultured
for three passages, during which no differences in average cell
size were found between the groups (Fig. 3b), nor in the pop-
ulation doubling time (Fig. 3c). Furthermore, cell surface
marker profiles of ASC, analyzed in passage 2, did not differ
between the three groups (Fig. 3d), showing a normal rat ASC
surface marker profile (van Dijk et al. 2011). Thus, the ASC
cultured from the SVF of all groups showed similar culture
characteristics.
Differentiation capacity after AMI
It was subsequently investigated whether AMI affected the
differentiation capacity of ASC in culture passage 1. To show
differentiation of the ASC towards adipocytes and osteoblasts,
ASC were stimulated with adipogenic and osteogenic
Fig. 1 Experimental set-up and
AMI. a Experimental set-up for
the three different groups:
Control, 1D and 7D. b
Representative microscopical
image of a PTAH staining to
confirm infarction. PTAH stains
viable cardiomyocytes purple (N
for normal tissue), and damaged
cells red/pink (I for infarcted
tissue). c Infarct size as
percentage of a heart slide. Infarct
size of the 1D group was 7.2±
2.8 % and 11.7±5.7 % in the 7D
group. Data shown as mean±SD
(7D group n=6, 1D group n=5)
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differentiation medium, for 7 and 12 days, respectively. For
both differentiation assays, non-stimulated ASC were added
as controls. In Fig. 4a, representative images of the differenti-
ation assays are shown, showing ALP staining for the stimu-
lated cells from Control, 1D and 7D groups, but not for the
non-stimulated ASC. In addition, lipid vesicles were present
in the stimulated cells from Control, 1D and 7D groups, but
not in the non-stimulated ASC. This indicates that all three
groups were still capable of differentiating towards osteoblasts
and adipocytes, respectively. Differentiation towards
cardiomyocytes was induced by stimulation with 5-aza-2-
deoxycytidine as described previously by van Dijk et al.
(2008). Microscopy images showed that the stimulated ASC
expressed connexin 43 and cTnI, markers of cardiomyocytes
(Naaijkens et al. 2012), while non-stimulated ASC did not
(Fig. 4b). No difference in the percentage of differentiated
ASC between all three groups was found for connexin 43
(Control group 91.4±3.3 %, 1D group 93.6±2.7 %, 7D group
93.7±1.9 %; Fig. 4c) and cTnI (Control group 79.8±8.2 %,
1D group 81.4±8.7 %, 7D group 78.0±13.8 %; Fig. 4c). As
such, ASC from both healthy control rats as well as from rats
that suffered AMI were capable of differentiating towards ad-
ipocytes, osteoblasts, and, most importantly, towards
cardiomyocytes.
Discussion
In clinical practice patients that suffered from AMI undergo-
ing stem cell therapy will receive autologous stem cells.
However, it is unknown whether AMI affects the patients’
own stem cells. In the present rat study we analyzed the puta-
tive effect of an AMI on ASC. We found that significantly
fewer ASC were present in the adipose tissue isolated one
day post-AMI compared with healthy controls and seven days
post-AMI, shown by a colony forming unit assay and cell
Fig. 2 Effect of AMI on rat SVF
cells. a Cell size (μm) of the SVF
cells, demonstrating no difference
between the three groups. b
Percentage of colony-forming
cells, showing significantly fewer
colonies in the 1D group (6.1±
1.6 %) compared to the Control
(11.4±1.8 %) and 7D groups
(11.0±0.9 %). c Number of cells,
obtained 4 days after seeding of
the SVF fraction, demonstrating
significantly fewer cells in the 1D
group (1.3±0.1 million cells)
compared to the Control (2.0±0.1
million cells) and 7D groups (1.8
±0.1 million cells). d Percentage
of positive cells for the markers
CD31, CD34, CD45, CD73,
CD90, CD105 and CD271
showing significantly fewer
CD90- and CD105-positive cells
in the 1D group. Data shown as
mean±SD (Control and 7D group
n=6, 1D group n=5, *p<0.05,
**p<0.01)
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surface marker profile of the SVF cells. Sham operations con-
firmed that the decrease in number of ASC was due to the
AMI, and not due to the operation. After culturing, ASC from
the three groups showed no differences in culture characteris-
tics, including cell size, proliferation rate or differentiation
capacity. Thus, AMI affected the number of stem cells in the
adipose tissue, but not their functional characteristics.
A possible explanation for the decrease in the number of
ASC could be that upon AMI they were mobilized into the
peripheral blood. This is in agreement with a number of stud-
ies that demonstrated a significant upregulation in the number
of stem cells in peripheral blood four days post-AMI in mice
(Dutta et al. 2012) and in patients one day post-AMI
(Wojakowski et al. 2006). In addition, the study of Iso et al.
(2012) described a significant increase in circulating mesen-
chymal stem cells in blood of patients three days after AMI,
compared to day zero and seven post-AMI, which is in
agreement with our rat study. These three studies suggested
that stem cells were mobilized from the bone marrow, assum-
ing all mesenchymal stem cells originate from the bone mar-
row. Now our results suggest that not only the bone marrow,
but also the adipose tissue may release stem cells after AMI,
which has to the best of our knowledge not been shown be-
fore. No distinction between ASC or bone marrowmesenchy-
mal stem cells can be made based solely on cell surface
markers, therefore we did not determine the number of cir-
culating ASC in peripheral blood. Another explanation for the
lower number of ASC present in the SVF one day after infarc-
tionmight be that ASC in the adipose tissue died one day post-
AMI due to the AMI-induced systemic inflammatory re-
sponse (Krijnen et al. 2006). However, this is unlikely, since
stem cells are able to resist hostile environments (van Dijk
et al. 2012). Furthermore, we found that seven days post-
AMI, the percentage of ASC in the adipose tissue was again
Fig. 3 Effect of AMI on cultured
rat ASC. a Representative light
microscopy image demonstrating
the morphology of cultured rat
ASC. b Cell size (μm) of ASC,
demonstrating no significant
differences between the three
groups. c Population doubling
time (in days) depicted for
passages 1–3, showing no
significant differences between
the three groups. d Percentage of
positive cells for the markers
CD31, CD34, CD45, CD73,
CD90, CD105 and CD271,
showing no significant
differences in numbers of positive
cells between the groups. Data
shown as mean±SD (Control and
7D group n=6, 1D group n=5)
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similar to that in healthy controls. This might be due to
proliferation of the ASC that remained in the adipose tissue,
or differentiation of early progenitor cells into ASC, to replen-
ish the depleted cells.
No other studies have investigated purely the effect of AMI
on ASC. However, there are other studies which have
analyzed the putative effects of aging or obesity on ASC. It
has been shown in vitro that aging negatively affected the
proliferation rate of human ASC, as well as the angiogenic
stimulatory capacity in tube-forming assays and differentia-
tion towards osteoblasts (Efimenko et al. 2011; Madonna
et al. 2011). It has also been shown that obesity significantly
Fig. 4 Multilineage differentation of rat ASC. (a) Representative images
showing differentiation of ASC towards osteoblasts, shown by ALP
staining, and adipocytes, shown by Oil Red O staining (a1-a4). No
staining is found in the non-stimulated cells (a5-a8). (b) Representative
images of differentiation towards cardiomyocytes, staining for connexin
43 (upper panel, b1-b4) and cTnI (lower panel, b5-b8) on cytospin slides.
(c) Bar graph showing quantification of the number of positive ASC for
cTnI (c1) and connexin 43 (c2) without (−) or stimulated (+) with 5-aza-2-
deoxycytidin. No significant differences in differentiation between the
three groups were found. Data shown as mean±SD (Control and 7D
group n=6, 1D group n=5)
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lowered the number of CD90-positive cells in the SVF frac-
tion of human obese patients, similar to the effect of AMI on
CD90-positive cells in our rat study. However, obesity also
negatively affected ASC in proliferation and differentiation
capacity towards adipocytes (Onate et al. 2012). Of course,
obesity is a long-term disease that develops in patients over a
period of several decades, in contrast to an acute myocardial
infarction induced in rats. This may explain the differences of
ASC concerning proliferation rate and differentiation capacity.
The percentage of patients that suffered AMI and also had
obesity is 28.9 %, a high incidence (Oda et al. 2012). Thus,
for the clinical situation, obesity might negatively affect ASC
therapy post-AMI.
In this study, it was shown that cultured ASC had the same
properties when isolated after AMI compared with healthy
controls. Proliferation rate as well as cell surface marker pro-
file and differentiation capacity towards cardiomyocytes of rat
ASC from the different groups were comparable to what has
been described previously for rat ASC (van Dijk et al. 2011;
Carvalho et al. 2013), suggesting that AMI did not affect the
functional characteristics of ASC. Furthermore, it was found
that the infarct size in the 1D group was lower compared to the
7D group, although this was not a significant difference. This
increase in infarct size can be explained by the post-AMI
induced inflammatory response, subsequently jeopardizing
cardiomyocytes (Krijnen et al. 2006; van Dijk et al. 2009).
In conclusion, we showed in rats that AMI affected
the composition of the SVF 1 day post-AMI via a de-
crease in the number of ASC; however, the ASC that
were present showed no functional differences.
Therefore, we hypothesize that stem cells can still be
isolated and applied 1 day post-AMI without having
any impairments in the functional characteristics of
ASC, including differentiation to cardiomyocytes when
applied as regenerative therapy. However, this should be
further investigated in future experiments to determine
whether these ASC also show a similar reparative ca-
pacity in vivo. Fortunately, adipose tissue is a rich
source of mesenchymal stem cells, providing sufficient
stem cells for cellular therapies at any time point of
isolation.
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